Evidence map›Paper›PMID 26236048›Full record

ArticleTetrahedron2015

Metal Catalyzed Allylic Alkylation: Its Development in the Trost Laboratories.

Barry M Trost

Abstract read
In one paragraph

Article in Tetrahedron, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Ligand-Controlled Alkylation-Heck-C(spJournal of the American Chemical Society · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cobalt-Catalyzed Decarboxylative Allylations: Development and Mechanistic Studies.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  15. Copper-Catalyzed Regiodivergent Internal Allylic Alkylations.Angewandte Chemie (International ed. in English) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Barry M TrostDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA, bmtrost@stanford.edu , phone: 650-723-3385, fax: 650-725-0002.

Funding

NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDSR01GM033049 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI TROST, BARRY M · 1985 to 2016
$6.5M
NIGMS NIH HHS R01 GM033049
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26236048
PMCPMC4517299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.